Metraipolis › archive › dc_591e9b04ec82

Resveratrol and Its Nitric Oxide-Donor Hybrid as an Emerging Therapy for Oxidative-Stress-Driven Priapism in Sickle Cell Disease — Europe PMC PMID:41154522

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41154522
DOI
10.3390/antiox14101213
License (as archived)
solo-consultazione
Archived
2026-11-09T12:19:42.277Z
SHA-256 of the archived text
b27ebe85fb22b6761668b38ab3d43042f7d72134fc7dfe3d0e267060fb20a57b
Stable URL of this page
https://metraipolis.com/documento/dc_591e9b04ec82

How to cite

Resveratrol and Its Nitric Oxide-Donor Hybrid as an Emerging Therapy for Oxidative-Stress-Driven Priapism in Sickle Cell Disease — Europe PMC PMID:41154522 — Europe PMC (en), https://europepmc.org/article/MED/41154522 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_591e9b04ec82 (Metraipolis archive dc_591e9b04ec82, sha256 b27ebe85fb22b6761668b38ab3d43042f7d72134fc7dfe3d0e267060fb20a57b)
BibTeX
@misc{dc591e9b04ec82,
  title = {Resveratrol and Its Nitric Oxide-Donor Hybrid as an Emerging Therapy for Oxidative-Stress-Driven Priapism in Sickle Cell Disease — Europe PMC PMID:41154522},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41154522},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_591e9b04ec82; sha256 b27ebe85fb22b6761668b38ab3d43042f7d72134fc7dfe3d0e267060fb20a57b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154522. Agents can read the archived copy with the MCP tool read_document.